Cartilage oLIGOMERIC mATRIX pROTEIN - Inflammation biomarker in knee osteoarthritis

Bosnian Journal of Basic Medical Sciences

Volumn 11, Issue 1, 2011, Pages 27-32

  Živanović, Sandra ^a   Rackov, Ljiljana Petrović ^b   Živanović, Aleksandar ^c   Jevtić, Milorad ^d   Nikolić, Sandra ^d   Kocić, Sanja ^d  

^a Health Center Kragujevac   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c CLINICAL CENTER KRAGUJEVAC   (Serbia)

^d UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Cartilage Oligomeric Matrix Protein; Effusion; Knee; Osteoarthritis; Synovitis

Indexed keywords

EID: 79952161655     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2011.2619     Document Type: Article

References (26)

1. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 1999; 7: 371-373.
2. Hill CL, Gale DG, Chaisson CE, Skinner K, Kazis L, Gale E, et al. Knee effusion, popliteal cysts, and synovial thickening: association with knee pain in osteoarthritis. J Rheumatol 2001; 28: 1330-1337.
3. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis predicts the arthroscopic progression of medial tibiofemoral knee osteoarthritis. Arthritis Rheum 2001; 44(9): 101.
4. Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin N Am 2004; 42: 1-9.
5. Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 2003; 30(5): 966-971.
6. Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006; 65: 1050-1054.
7. Garnero P. New biochemical markers of cartilage turnover in osteoarthritis: recent developments and remaining challenges. IBMS BoneKEy 2007; 4(1): 7-18.
8. Garnero P, Mazières B, Guéguen A, Abbal M, Berdah L, Lequesne M et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J Rheumatol 2005; 32(4): 697-703.
9. Borovecki F, Pecina-Slaus N, Vukicevic S. Biological mechanisms of bone and cartilage remodeling - genomic perspective. Int Orthop 2007; 31: 799-805.
10. Kraus VB. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2005; 17: 641-646.
11. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 2001; 60: 619-626.
12. Berger C, Kröner A, Stiegler H, Thomas Leitha T, Engel A. Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip. Int Orthop 2005; 29(1): 1-5.
13. Vjollca SM, Sylejman R, Suzana MK, MR. Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis. Bosnian journal of basic medical sciences 2010; 10(1): 26-31.
14. Clark AG, Jordan JM, Vilim V, Renner JB, Dragomir AD, Luta G, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity. Arthritis Rheum 1999; 42: 2356-2364.
15. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992; 267: 6132-6136.
16. Muller G, Michel A, Altenburg E. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage. Connect Tissue Res 1998; 39: 233-244.
17. Heinegård D, Lorenzo P, Saxne T. Matrix glycoproteins and proteoglycans in cartilage. In; Harris ED Jr, Budd RC, Genovese MC, et al (eds). Kelley's textbook of rheumatology, 7th edn. Philadelphia: Elsevier Saunders; 2005, pp. 48-62.
18. Larsson E, Erlandsson Harris H, Larsson A, Månsson B, Saxne T, Klareskog L. Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology 2004; 43: 428-434.
19. Jung YO, Do JH, Kang HJ, Yoo SA, Yoon CH, Kim HA, et al. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients. Clin Exp Rheumatol 2006; 24(3): 253-259.
20. Vilím V, Olejárová M, Machácek S, Gatterová J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002; 10(9): 707-713.
21. D'Agostino MA, Conaghan P, Le Bars M, Baron G, Grassi W, Martin-Mola E, et al. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis 2005: 64(12): 1703-1709.
22. Conaghan P, D'Agostino MA, Ravaud P, Baron G, Le Bars M, Grassi W, et al. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 2: exploring decision rules for clinical utility. Ann Rheum Dis 2005; 64(12): 1710-1714.
23. Mendieta ME, Cobo Ibanez T, Uson Jaeger J, Bonilla Hernan G, Martin Mola E. Clinical and ultrasonographic findings related to knee pain in osteoarthritis. Osteoarthritis Cartilage 2006; 14(6): 540-544.
24. Maiko O, Bagirova GG, Popova LV. Diagnostic possibilities of ultrasonic scanning of the knee joints in osteoarthrosis. Ter Arkh 2005; 77(4): 44-50.
25. Andersson MlE, Petersson IF, Karlsson KE, Jonsson EN, Månsson B. Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1490-1494.
26. Sharif M, Granell R, Johansen J, Clarke S, Elson C, Kirwan JR. Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee. Rheumatology 2006; 45(5): 522-526.